Treatment of Gastroesophageal Reflux Disease: To Step or Not to Step

McGuigan, James E.
June 2001
American Journal of Gastroenterology;Jun2001, Vol. 96 Issue 6, p1679
Academic Journal
Discusses the therapeutic approach for gastroesophageal reflux disease (GERD). Prevalence of GERD in the U.S.; Symptoms of GERD; Comparisons of the principal treatment regimens for GERD.


Related Articles

  • Natural Relief from HEARTBURN. Martin, Russell // Life Extension;Sep2006, Vol. 12 Issue 9, p22 

    The article reports on the cure for gastroesophageal reflux disease (GERD), a condition that occurs when digestive liquids regurgitate from the stomach into the esophagus. Clinical data suggest that d-limonene, a nutrient derived from orange peel oil, offers hope to those with symptoms with...

  • Lansoprazole Heals Erosive Reflux Esophagitis Resistant to Histamine H2-Receptor Antagonist Therapy. Sontag, Stephen J.; Kogut, David G.; Fleischmann, Roy; Campbell, Donald R.; Richter, Joel; Robinson, Malcolm; McFarland, Miles; Sabesin, Seymour; Lehman, Glen A.; Castell, Donald // American Journal of Gastroenterology;Mar1997, Vol. 92 Issue 3, p429 

    Purpose: We conducted a randomized, double-blind, multicenter clinical trial to determine whether lansoprazole was superior to continued therapy with histamine H2-receptor antagonist therapy in healing erosive reflux esophagitis. Methods: Investigators from nine medical centers enrolled 159...

  • “Refractory GERD”: Acid, Nonacid, or Not GERD? Vaezi, Michael F. // American Journal of Gastroenterology;Jun2004, Vol. 99 Issue 6, p989 

    Gastroesophageal reflux disease (GERD) is a common condition with 44% of Americans surveyed reporting heartburn at least once a month and 20% once a week (). However, despite major advances in our understanding of this disease, management of GERD is still a challenge. Proton pump inhibitors...

  • Delivery of radiofrequency energy to the gastroesophageal junction (Stretta procedure) for the treatment of gastroesophageal reflux disease. Cipolletta, L.; Rotondano, G.; Dughera, L.; Repici, A.; Bianco, M. A.; De Angelis, C.; Vingiani, A. M.; Battaglia, E. // Surgical Endoscopy;Jun2005, Vol. 19 Issue 6, p849 

    Background: Radiofrequency (RF) energy treatment is increasingly offered before invasive surgical procedures for selected patients with gastroesophageal reflux disease (GERD).Methods: Thirty-two patients undergoing the Stretta procedure were prospectively evaluated with...

  • GERD BEYOND THE ESOPHAGUS. Magill-Lewis, Jillene // Drug Topics;4/15/2002, Vol. 146 Issue 8, p62 

    Provides information on the gastroesophageal reflux disease. Symptoms; Developments in drugs for treatment of the disease; Role of pharmacists in the treatment of the disease.

  • hard to swallow. Drury, Kathryn // Vegetarian Times;Apr2001, Issue 284, p68 

    Focuses on gastroesophageal reflux disease (GERD), a condition characterized by frequent occurrence of heartburn. Pathophysiology; Causes; Foods that can help relieve the pain; Role of stress in increasing risks for GERD.

  • High- Versus Standard-Dose Ranitidine for Control of Heartburn in Poorly Responsive Acid Reflux Disease: A Prospective, Controlled Trial. Kahrilas, Peter J.; Fennerty, M. Brian; Joelsson, Bo // American Journal of Gastroenterology;Jan1999, Vol. 94 Issue 1, p92 

    Objective: H2-receptor antagonists are commonly used as initial therapy in patients with gastroesophageal reflux disease (GERD) and are frequently continued at the same or higher doses when symptoms persist after 4-6 wk of therapy. Our objective was to compare the efficacy of twice-daily...

  • Treatment of Reflux Esophagitis Resistant to H2-Receptor Antagonists with Lansoprazole, a New H+/K+-ATPase Inhibitor: A Controlled, Double-Blind Study. Feldman, Mark; Harford, William V.; Fisher, Robert S.; Sampliner, Richard E.; Murray, Susan B.; Greski-Rose, Pamela A.; Jennings, Dennis E. // American Journal of Gastroenterology;Aug1993, Vol. 88 Issue 8, p1212 

    This multicenter, randomized, double-blind, 8-wk study compared the new H+/K+-ATPase inhibitor, lansoprazole, 30 mg daily, to ranitidine 150 mg bid for treatment of erosive reflux esophagitis resistant to histamine-2 receptor antagonists (H2RA). Patients were evaluated after 2, 4, 6, and 8 wk of...

  • Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole. Taghavi, S. A.; Ghasedi, M.; Saberi-Firoozi, M.; Alizadeh-Naeeni, M.; Bagheri-Lankarani, K.; Kaviani, M. J.; Hamidpour, L. // Gut;Aug2005, Vol. 54 Issue 8, p1067 

    Background: Twenty four hour oesophageal pH monitoring is frequently used to quantify the association between a patient's symptom and gastro-oesophageal reflux. Three indices (symptom association probability (SAP), symptom index (SI), and symptom sensitivity index (SSI)) are used to quantify and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics